Department of Health Behavior and Policy, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
VCU Massey Cancer Center Office of Health Equity and Disparities Research, Richmond, Virginia, USA.
J Womens Health (Larchmt). 2021 Sep;30(9):1321-1327. doi: 10.1089/jwh.2020.8502. Epub 2021 Jan 11.
Inclusion of women in biomedical cancer research have the potential to close gaps in cancer health disparities and improve adjuvant therapies for women; yet samples needed to advance this area of science are lacking. We developed low-cost educational recruitment strategies to increase our collection of biospecimens from women. Women diagnosed with hormone receptor positive (HR+) breast cancer that initiated hormonal therapy were recruited from three integrated health systems. The analytical sample ( = 144) consisted of women who consented but did not return a saliva sample within 1 year of the initial assessment (baseline). Brief informational recruitment materials were developed published literature and preliminary data. Women received recruitment materials, which included a personalized information letter, a colorful low-literacy instruction sheet, a postage-paid envelope, and collection kits. We evaluated intervention materials and performed descriptive and bivariate statistics to describe factors associated with biospecimen donation. Of the total sample, 61% were white and 34% were black. Overall, 29 surveys (20%) and 25 (17%) saliva kits were returned. Women found the materials helpful and easy to read and understand. Women with higher levels of functional well-being and lower ratings of religiosity were more likely to return biospecimens ( < 0.005) after receiving enhanced materials. This article provides recruitment strategies to enhance biospecimen samples among women. Receipt of brief informational print materials inclusive of personalized messages enhanced our outreach strategies and increased our overall biospecimen provision rate by 17%. The inclusion of messages with a focus on spirituality and other cultural messages may further increase biospecimen provision in racial/ethnic diverse groups of women; however, further study is needed to support this claim. Clinical Trail Registration Number: NCT02992730.
纳入女性参与癌症生物医学研究,有可能缩小癌症健康差异,并改善女性辅助治疗;但缺乏推进这一科学领域所需的样本。我们制定了低成本的教育招募策略,以增加我们从女性身上采集生物样本。从三个综合健康系统中招募了诊断为激素受体阳性(HR+)乳腺癌且开始激素治疗的女性。分析样本(n=144)由同意但在初始评估(基线)后 1 年内未返回唾液样本的女性组成。简要的信息性招募材料是根据文献和初步数据开发的。女性收到了招募材料,包括个性化信息信、色彩鲜艳的低识字说明、邮资已付的信封和采集套件。我们评估了干预材料,并进行了描述性和双变量统计分析,以描述与生物样本捐赠相关的因素。在总样本中,61%为白人,34%为黑人。总的来说,有 29 份(20%)调查问卷和 25 份(17%)唾液试剂盒被寄回。女性认为材料有用,阅读和理解起来也很容易。功能健康水平较高和宗教信仰程度较低的女性在收到增强型材料后更有可能归还生物样本(<0.005)。本文提供了增强女性生物样本采集的招募策略。接收包含个性化信息的简短信息印刷材料增强了我们的外展策略,并使我们的生物样本提供率总体提高了 17%。纳入以精神信仰和其他文化信息为重点的信息可能会进一步增加不同种族/民族女性的生物样本提供率;但需要进一步研究来支持这一说法。临床试验注册号:NCT02992730。